NextPlat (NXPL) Non-Current Debt (2019 - 2026)
NextPlat's (NXPL) quarterly Non-Current Debt came in at $1.0 million in Q2 2026, down 13.15% year-over-year from $1.2 million in Q2 2025, and down 12.77% quarter-over-quarter from $1.2 million in Q1 2026.
Analysis
NextPlat (NXPL) Non-Current Debt (2019 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Non-Current Debt for 8 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 13.15% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 13.15% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 8.5% from the prior year.
- Non-Current Debt was $1.0 million for Q2 2026 at NextPlat, down from $1.2 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $1.6 million in Q3 2023 and troughed at $131607.0 in Q2 2023.
- A 5-year average of $940935.1 and a median of $1.2 million in 2025 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt tumbled 41.18% in 2022 and surged 936.01% in 2023, its largest moves.
- Over 5 years, Non-Current Debt stood at $216000.0 in 2022, then jumped by 605.09% to $1.5 million in 2023, then declined by 7.29% to $1.4 million in 2024, then retreated by 8.5% to $1.3 million in 2025, then retreated by 22.29% to $1.0 million in 2026.
- The last three Non-Current Debt figures came in at $1.0 million (Q2 2026), $1.2 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 12.09 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 11.61 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 150.67 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 2.57 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 20.74 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 280.16 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.26 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 609.56 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 131,607.00 |
| Mar 31, 2023 | 144,293.00 |
| Dec 31, 2022 | 216,000.00 |
| Sep 30, 2022 | 157,958.00 |
| Jun 30, 2022 | 187,544.00 |
| Mar 31, 2022 | 218,967.00 |
| Dec 31, 2021 | 253,757.00 |
| Sep 30, 2021 | 268,528.00 |